Renal Cell Carcinoma

AI-driven DNA methylation liquid biopsy shows promise in brain and kidney cancer

The method -- called cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq) -- has been developed for blood and other kinds of liquid specimens. Testing screens for abnormal methylation, whereas liquid biopsy tests typically look for mutations, the researchers explained.

June 23, 2020

Google reports pathology AI helps predict survival in cancer patients

The deep-learning system was developed and tested using histopathology slides for patients with 10 cancer types -- including bladder cancer, invasive breast cancer, and head and neck squamous cell carcinoma -- drawing from publicly available data from the Cancer Genome Atlas (TCGA) program.

June 17, 2020

Most Popular

Genetic causes identified for three rare diseases

Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease

SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests

Duke University researchers discover biomarkers may identify early pancreatic cancer risk

Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition

Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu